February 13, 2024 · Form 4 insider transaction
Bay Shore Trust bought 49,000 shares of Telomir Pharmaceuticals, Inc. at $7.00 per share, a transaction worth $343.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.